# Xencor Inc: filings

XNCR · Nasdaq · CIK 1326732 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xncr.md) · [Financials](/companies/xncr/financials.md) · [Filings](/companies/xncr/filings.md) · [Insiders](/companies/xncr/insiders.md)

## Reports and events: 222 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 359, 8-K 135, SC 13G/A 68, 144 57, 10-Q 38, 3 29, SC 13G 21, 4/A 15, 10-K 13, DEF 14A 13, DEFA14A 12, CORRESP 11, SC 13D/A 11, CT ORDER 10, SCHEDULE 13G/A 10, 424B5 9, 3/A 8, UPLOAD 7, ARS 6, S-8 6, D 4, S-1/A 4, S-8 POS 4, SCHEDULE 13G 4, 10-Q/A 3, EFFECT 3, S-3ASR 3, 10-K/A 2, 5 2, S-3 2, SEC STAFF LETTER 2, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, DEFR14A 1, DRS 1, DRSLTR 1, S-1 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 07:50 ET | [8-K](/filings/0001213900-26-112279.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-112279 |
| 2026-08-05 | 16:02 ET | [10-Q](/filings/0001326732-26-000056.md) | Quarterly report, period 2026-06-30 | 0001326732-26-000056 |
| 2026-08-05 | 16:01 ET | [8-K](/filings/0001326732-26-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-26-000055 |
| 2026-07-29 | 16:05 ET | [8-K](/filings/0001326732-26-000049.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326732-26-000049 |
| 2026-06-18 | 16:43 ET | [8-K](/filings/0001326732-26-000045.md) | 5.07 Shareholder vote results | 0001326732-26-000045 |
| 2026-05-06 | 16:02 ET | [10-Q](/filings/0001326732-26-000043.md) | Quarterly report, period 2026-03-31 | 0001326732-26-000043 |
| 2026-05-06 | 16:01 ET | [8-K](/filings/0001326732-26-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-26-000042 |
| 2026-05-05 | 08:41 ET | [8-K](/filings/0001326732-26-000036.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326732-26-000036 |
| 2026-04-27 | 16:02 ET | [DEF 14A](/filings/0001326732-26-000031.md) | Proxy statement, period 2026-04-27 | 0001326732-26-000031 |
| 2026-04-27 | 16:01 ET | [8-K](/filings/0001326732-26-000030.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326732-26-000030 |
| 2026-03-09 | 16:01 ET | [8-K](/filings/0001326732-26-000023.md) | 1.02 Termination of a material agreement | 0001326732-26-000023 |
| 2026-03-04 | 16:01 ET | [8-K](/filings/0001326732-26-000021.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326732-26-000021 |
| 2026-02-25 | 16:02 ET | [10-K](/filings/0001326732-26-000015.md) | Annual report, period 2025-12-31 | 0001326732-26-000015 |
| 2026-02-25 | 16:01 ET | [8-K](/filings/0001326732-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-26-000014 |
| 2026-01-08 | 08:05 ET | [8-K](/filings/0001326732-26-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-26-000002 |
| 2025-11-05 | 16:03 ET | [10-Q](/filings/0001326732-25-000087.md) | Quarterly report, period 2025-09-30 | 0001326732-25-000087 |
| 2025-11-05 | 16:02 ET | [8-K](/filings/0001326732-25-000086.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-25-000086 |
| 2025-10-24 | 13:57 ET | [8-K](/filings/0001326732-25-000082.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326732-25-000082 |
| 2025-08-06 | 16:02 ET | [10-Q](/filings/0001326732-25-000075.md) | Quarterly report, period 2025-06-30 | 0001326732-25-000075 |
| 2025-08-06 | 16:01 ET | [8-K](/filings/0001326732-25-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-25-000074 |
| 2025-07-31 | 16:02 ET | [8-K](/filings/0001326732-25-000063.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326732-25-000063 |
| 2025-06-13 | 16:01 ET | [8-K](/filings/0001326732-25-000057.md) | 5.07 Shareholder vote results | 0001326732-25-000057 |
| 2025-05-07 | 16:09 ET | [10-Q](/filings/0001326732-25-000053.md) | Quarterly report, period 2025-03-31 | 0001326732-25-000053 |
| 2025-05-07 | 16:03 ET | [8-K](/filings/0001326732-25-000052.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326732-25-000052 |
| 2025-04-30 | 18:01 ET | [8-K](/filings/0001326732-25-000048.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326732-25-000048 |
| 2025-04-23 | 16:05 ET | [DEF 14A](/filings/0001326732-25-000043.md) | Proxy statement, period 2025-04-23 | 0001326732-25-000043 |
| 2025-03-13 | 16:42 ET | [8-K/A](/filings/0001326732-25-000037.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001326732-25-000037 |
| 2025-03-13 | 16:01 ET | [8-K](/filings/0001326732-25-000035.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326732-25-000035 |
| 2025-03-05 | 16:03 ET | [8-K](/filings/0001326732-25-000032.md) | 4.01 Change of auditor | 0001326732-25-000032 |
| 2025-02-27 | 08:05 ET | [10-K](/filings/0001326732-25-000029.md) | Annual report, period 2024-12-31 | 0001326732-25-000029 |
| 2025-02-27 | 08:02 ET | [8-K](/filings/0001326732-25-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-25-000028 |
| 2025-02-24 | 08:08 ET | [10-Q/A](/filings/0001326732-25-000021.md) | Quarterly report, amended, period 2024-09-30 | 0001326732-25-000021 |
| 2025-02-24 | 08:06 ET | [10-Q/A](/filings/0001326732-25-000019.md) | Quarterly report, amended, period 2024-06-30 | 0001326732-25-000019 |
| 2025-02-24 | 08:04 ET | [10-Q/A](/filings/0001326732-25-000017.md) | Quarterly report, amended, period 2024-03-31 | 0001326732-25-000017 |
| 2025-02-24 | 08:02 ET | [10-K/A](/filings/0001326732-25-000015.md) | Annual report, amended, period 2023-12-31 | 0001326732-25-000015 |
| 2025-02-13 | 08:00 ET | [8-K](/filings/0001326732-25-000005.md) | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001326732-25-000005 |
| 2025-01-13 | 08:08 ET | [8-K](/filings/0001326732-25-000002.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326732-25-000002 |
| 2024-11-06 | 16:09 ET | [10-Q](/filings/0001326732-24-000060.md) | Quarterly report, period 2024-09-30 | 0001326732-24-000060 |
| 2024-11-06 | 16:03 ET | [8-K](/filings/0001326732-24-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-24-000059 |
| 2024-10-04 | 08:15 ET | [8-K](/filings/0001326732-24-000052.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326732-24-000052 |
| 2024-09-12 | 16:02 ET | [8-K](/filings/0001326732-24-000048.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326732-24-000048 |
| 2024-09-12 | 08:47 ET | [8-K](/filings/0001213900-24-077934.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-077934 |
| 2024-09-09 | 09:00 ET | [8-K](/filings/0001326732-24-000046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326732-24-000046 |
| 2024-08-05 | 16:12 ET | [10-Q](/filings/0001326732-24-000043.md) | Quarterly report, period 2024-06-30 | 0001326732-24-000043 |
| 2024-08-05 | 16:06 ET | [8-K](/filings/0001326732-24-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-24-000041 |
| 2024-06-14 | 16:03 ET | [8-K](/filings/0001326732-24-000036.md) | 5.07 Shareholder vote results | 0001326732-24-000036 |
| 2024-06-13 | 08:05 ET | [8-K](/filings/0001326732-24-000034.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326732-24-000034 |
| 2024-05-09 | 16:11 ET | [8-K](/filings/0001326732-24-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326732-24-000030 |
| 2024-05-09 | 16:02 ET | [10-Q](/filings/0001326732-24-000029.md) | Quarterly report, period 2024-03-31 | 0001326732-24-000029 |
| 2024-04-24 | 16:05 ET | [DEF 14A](/filings/0001326732-24-000017.md) | Proxy statement, period 2024-04-24 | 0001326732-24-000017 |

Page 1 of 5. [Older](/companies/xncr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:42 ET. No prices; not investment advice.